Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

PHASE3CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Allergic RhinitisPerennial Allergic RhinitisNon-seasonal Allergic Rhinitis
Interventions
DRUG

AGR tablet

DRUG

Placebo (for AGR tablet and/or Active Comparator)

DRUG

Active Comparator

Trial Locations (9)

463-707

Seoul National University Bundang Hospital, Seongnam-si

402-751

Inha University Hospital, Incheon

110-744

Seoul National University Hospital, Seoul

120-751

Severance Hospital, Seoul

130-872

Kyung Hee University Medical Center, Seoul

135-710

Samsung Medical Center, Seoul

137-701

Seoul St. Mary's Hospital, Seoul

143-729

Konkuk University Medical Center, Seoul

156-707

SMG-SNU Boramae Medical Center, Seoul

All Listed Sponsors
collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Kyunghee University Medical Center

OTHER

collaborator

Konkuk University Medical Center

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Severance Hospital

OTHER

lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT01982916 - Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean | Biotech Hunter | Biotech Hunter